layoffs

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Beckman Coulter's president has issued a letter to employees informing them that 8 percent of the company's workforce will be laid off as part of the company's restructuring.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PerkinElmer reduced its number of employees by 72 as part of a restructuring plan during its recently completed second quarter, the company disclosed this week.

The company said in an SEC document it will shrink its workforce by 10 to 15 employees in connection with the integration of its Symyx acquisition.

LabCorp plans to integrate Genzyme Genetics' reimbursement and IT teams at the Westborough, Mass., facility into its own operations.

The firm's Pharmaceutical Divisions will be primarily affected by the job cuts and transfers. The program is expected to result in annual cost savings of CHF2.4 billion ($2.4 billion) for Roche.

The firm also will consolidate its R&D work and leave open job positions unfilled.

The firm's lab services revenues were hurt by lower sample volume, but were partially offset by a higher average price per sample. Celera also announced a restructuring program intended to cut costs by $10 million next year.

The firm, which has been unable to complete a US IPO, has cut staff, consultants, and its board of directors as it seeks funding and potential strategic alternatives.

The cost-cutting moves, which are expected to reduce Rosetta's annual operating costs by $4 million, come less than a month after the Israeli firm unveiled two new microRNA-based tests it has under development and said that it would be establishing its own sales force to market them and certain other of its next-generation products.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.